PTC Therapeutics | PTCT - Cassa E Equivalenti





Cassa E Equivalenti Cambiamento Data
Acadia Pharmaceuticals USD 819.69M 27.33M 2025-12
Alnylam Pharmaceuticals USD 1.71B 53.53M 2026-03
Amgen USD 12.04B 2.91B 2026-03
BioCryst Pharmaceuticals USD 335.91M 251.83M 2025-12
Biogen USD 3.38B 374.2M 2026-03
BioMarin Pharmaceutical USD 2.22B 910.76M 2026-03
Cytokinetics USD 129.84M 7.32M 2026-03
Daiichi Sankyo JPY 542.16B 97.68B 2025-09
Enanta Pharmaceuticals USD 37.44M 5.14M 2025-12
Esperion Therapeutics USD 92.45M 6.39M 2025-09
Gilead Sciences USD 7.56B 234M 2025-12
Incyte USD 4.02B 435.22M 2026-03
Ionis Pharmaceuticals USD 1.92B 758M 2026-03
Ironwood Pharmaceuticals USD 140.41M 47.56M 2025-09
Karyopharm Therapeutics USD 60.54M 22.87M 2025-12
Novartis USD 6.88B 4.56B 2026-03
Pfizer USD 1.7B 561M 2026-03
PTC Therapeutics USD 984.65M 312.03M 2025-12
Puma Biotechnology USD 53.52M 1.14M 2025-09
Roche Holding CHF 7.55B 579M 2025-06
Sangamo BioSciences USD 38.34M 13.16M 2025-06
Sarepta Therapeutics USD 801.28M 188.2M 2025-12
TG Therapeutics USD 199.51M 21.2M 2025-12
Ultragenyx Pharmaceutical USD 175M 246M 2026-03
Vertex Pharmaceuticals USD 7.25B 638.6M 2026-03
Xencor USD 54.07M 25.78M 2025-12